Introduction
Retinoic acid-inducible gene-(RIG-) was identified as a gene induced by retinoic acid in the NB4 human promyelocytic leukemic cell line 1) . RIG-has a DExH motif and is regarded as a putative RNA helicase. We identified RIG-among the genes induced by lipopolysaccharide in endothelial cells 2) . RIG-is also induced in endothelial cells in response to interferon-(IFN-) 3) and polyinosinic-polycytidylic acid, synthentic double-stranded RNA 4) . IFN-induces the expression of RIG-in other types of cells including smooth muscle cells 5) , T24 bladder epithelial cells 6) , BEAS-2B bronchial epithelial cells 7) and MCF-7 breast cancer cells 8) . Another pro-inflammatory cytokine, interleukin (IL)-1 , induces RIG-expression in gingival fibroblasts 9) . RIG-thus may be also implicated in inflammatory responses, although RIG-was first identified as a gene expressed during cellular differentiation.
Chronic inflammation is one of the pathogenetic components of atherosclerosis 10) , and proinflammatory cytokines and the products of their target genes play important roles in atherosclerosis 11) ; therefore, RIGmay be involved as a gene related to the regulation of inflammatory responses in the pathogenesis of atherosclerosis. In the present study, we examined the expression of RIG-in atherosclerotic lesions and addressed the possible involvement of RIG--expressing macrophages in atherosclerosis.
Materials and Methods

Reagents
An anti-RIG-antibody was raised in a rabbit as described previously 3) . The mouse monoclonal antibody against CD68 was from DakoCytomation (Kyoto, Japan). RPMI-1640 medium, fetal bovine serum (FBS), oligo(dT)12-18 primer, M-MLV reverse transcriptase were from Invitrogen (Carlsbad, CA, USA). Phorbol 12-myristate 13-acetate (PMA) was from Biomol (Plymouth Meeting, PA, USA). IFN-was from Roche (Manheim, Germany). Ficoll-Paque Plus was from Amersham Pharmacia Biotech (Uppsala, Sweden). The RNeasy kit and Taq DNA polymerase were from Qiagen (Hilden, Germany). The Immobilon-P polyvinylidine difluoride (PVDF) membrane was from Nihon Millipore (Tokyo, Japan). Anti-actin rabbit IgG was from Sigma (St. Louis, MA, USA). The anti-rabbit IgG antibody labeled with horseradish peroxidase (HRP) was from Kirkegaard Perry (Gaithersburg, MD, USA). The SuperSignal West Pico chemiluminescence substrate was from Pierce (Rockford, IL, USA). The LightCycler FastStart DNA Master SYBR Green I kit and LightCycler-primer set for porphobilinogen deaminase (PBGD) were from Roche (Mannhaim, Germany). The LightCycler-primer set for RIG-was made by Nihon Gene Research (Sendai, Japan).
Immunohistochemistry
The expression of RIG-in the aorta obtained from autopsied patients was examined by immunohistochemistry as described previously 3, 6) . Briefly, deparaffinized tissue sections were incubated sequentially with an anti-RIG-antibody (1:1000), anti-CD68 antibody (1:100) or non-immune control antibody, and then the samples were incubated with a biotinylated secondary antibody and HRP-streptavidin. Immunoreactivity was detected using the DAB/H2O2 system. The nuclei were counterstained with hematoxylin. Histological specimens were retrieved from materials archives in the Department of Pathology, Hirosaki University School of Medicine under the guidelines for the use of stored human paraffin blocks issued by the Japanese Society of Pathology.
Cells
THP-1 cells, a human monocytic leukemia cell line, were cultured in RPMI-1640 containing 10% FBS (RPMI-FBS). For induction into macrophage-like differentiation, the cells were treated for up to three days with 100 ng/mL PMA.
Human monocyte-derived macrophages were cultured as described previously 12) . Briefly, peripheral venous blood was drawn from healthy volunteers and monocytes were isolated using Ficoll-Paque Plus. The cells were cultured using RPMI-FBS for two or four days to differentiate into macrophages and stimulated with 10 ng/mL IFN-for an additional day.
Western Blot Analysis
Cells were lysed using Laemmli's reducing sample buffer. The lysate was subjected to electrophoresis on a 6-9% gradient polyacrylamide gel, and the proteins were transferred to an Immobilon-P PVDF membrane. RIG-protein was detected using an anti-RIG-antibody (1:10000 dilution) as described 2) . Actin was detected using anti-actin rabbit IgG (1:250 dilution). Immunodetection was performed using a HRP-labeled anti-rabbit IgG antibody and a SuperSignal West Pico chemiluminescence substrate.
RNA Extraction and RT-PCR Analysis
Total RNA was extracted from the cells using an RNeasy kit. Single-strand cDNA was synthesized from 1 g of total RNA using an oligo(dT)12-18 primer and M-MLV reverse transcriptase. The cDNA for RIG-, CD68 13) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified by PCR using Taq DNA polymerase and the specific primers shown in Table  1A . The products were analyzed by electrophoresis on a 1.5% agarose gel containing ethidium bromide.
Quantitative analysis of RIG-mRNA was performed by real-time PCR using a LightCycler V3 system according to the manufacturer's protocol. The primers for RIG-are shown in Table 1B . RIG-mRNA level was expressed as the ratio to reference PBGD mRNA.
Results
Intimal Macrophages Express RIG-
Intense immunoreactivity for RIG-was observed in intimal macrophages (Fig. 1A, B ) in the aorta with atherosclerotic lesions. Cells expressing RIG-were also stained positively with an antibody against CD68, a specific marker for macrophages (Fig. 1C) . There was no positive signal in the control section (Fig. 1D) .
Expression of RIG-in Macrophages in Culture
Minimal expression of RIG-was observed in THP-1 cells without treatment. RIG-expression was slightly induced in response to treatment with PMA or IFN- (Fig. 2) ; and co-treatment of THP-1 cells with PMA and IFN-significantly enhanced the expression of RIG-protein and mRNA in a time-dependent manner (Fig. 2) . RIG-mRNA expression was strongly enhanced one day after treatment and decreased thereafter.
The expression of RIG-protein lagged behind the mRNA expression, and peaked two days after treatment. IFN--induced expression of RIG-in PMAtreated cells was observed in a concentration-dependent manner (Fig. 3A, B) . IFN--induced upregulation of RIG-mRNA was confirmed by real-time quantitative PCR (Fig. 3C) .
IFN-also induced the expression of RIGmRNA in human monocyte-derived macrophages cultured for two days but not in the cells cultured for four days (Fig. 4) . Differentiation of the cells into macrophages was confirmed by the increased expression of CD68 mRNA.
Discussion
In the present study, we detected the expression of RIG-in atherosclerotic tissues from human aorta. RIG-immunoreactivity was observed in intimal macrophages in atherosclerotic lesions. The expression of RIG-was verified by in vitro studies using macrophages in culture. Only a low level of RIG-expression was detected in control THP-1 cells, but the differentiation of THP-1 cells, with PMA treatment, into macrophage-like cells slightly enhanced the expression, and this is in keeping with the original observation that RIG-was identified among the genes induced during retinoic acid-induced differentiation of leukemic cells. RIG-expression in PMA-differentiated THP-1 cells was markedly enhanced in response to IFN-. The expression of RIG-mRNA was highly enhanced 24 h after stimulation with IFN-and decreased thereafter. The expression of RIG-protein lagged behind the mRNA expression and peaked two days after treatment. The time course of the IFN--induced expres- sion of RIG-in THP-1 cells was different from that in endothelial cells 3) or vascular smooth muscle cells 5) , and this suggests that the expression of RIG-is differentially regulated among these cell types.
We also confirmed the IFN--induced expression of RIG-mRNA in human monocyte-derived macrophages cultured for two days. IFN-did not induce RIG-mRNA in macrophages cultured for four days, while the expression of CD68, a marker of macrophage differentiation, was higher in cells cultured for four days as compared to two days. The expression of RIGis not associated precisely with the macrophage differentiation defined by CD68 expression.
IFN-is expressed at high levels in atherosclerotic tissues 11) and is considered one of the key factors in atherogenesis 14) . IFN-has been shown to stimulate the expression of RIG-in various cell types 3, [5] [6] [7] [8] , and RIG-may be implicated in the regulation of macrophage function by IFN-. RIG-is a member of the DExH protein family, which is known to be involved in a wide range of RNA metabolism including transcription, splicing, ribosome biosynthesis, translation and degradation 15) . Macrophage function may be mediated by RIG-through the regulation of RNA metabolism; however, details of the molecular functions of RIG-are not known.
The generation of various chemokines and inflammatory responses is one of the pathophysiological components of atherosclerosis 16) . We have previously found that overexpression of RIG-resulted in the enhanced production of chemokines, such as CXCL10 and CXCL1, in bronchial epithelial cells 7, 17, 18) . Decreased expression of CXCL10 and CCL5 was demonstrated in mouse embryonic fibroblasts that lack Peripheral blood monocytes were isolated and cultured for 2 or 4 days, and stimulated with 10 ng/mL IFN-for 1 day. Total RNA was extracted and RT-PCR for RIG-or CD68 was performed.
RIG- 19) . The regulation of chemokine generation in macrophages may account for the role of RIG-in atherosclerosis.
Endothelial cells are activated by factors such as cytokines, and adhesion molecules are expressed on the surface of the endothelium, which leads to the adherence of circulating monocytes to the endothelial surface and their migration into the intima of the arterial wall. Migrated monocytes differentiate into macrophages, and macrophages are transformed into foam cells upon taking up modified lipoproteins.
In summary, IFN-induces RIG-expression in macrophages, which may be implicated in the role of macrophages in atherosclerosis.
